Cite
HARVARD Citation
Kirste, S. et al. (n.d.). PO-1231 Response to neoadjuvant RCT as a predictor for overall survival in therapy of esophageal cancer. Radiotherapy and oncology. pp. S1017-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kirste, S. et al. (n.d.). PO-1231 Response to neoadjuvant RCT as a predictor for overall survival in therapy of esophageal cancer. Radiotherapy and oncology. pp. S1017-. [Online].